Home/CellTrans/Giovanna La Monica, PhD
GL

Giovanna La Monica, PhD

Chief Quality Officer

CellTrans

Therapeutic Areas

CellTrans Pipeline

DrugIndicationPhase
LANTIDRA (donislecel-jujn)Type 1 Diabetes with severe hypoglycemiaApproved